Intrathecal Drug Delivery Systems for Cancer Pain: A Health Technology Assessment [0.03%]
用于癌症疼痛的鞘内给药系统：健康技术评估
Ontario Health
Ontario Health
Background: Pain is a common and very distressing symptom for adults and children with cancer. Compared with other routes of delivery, infusing pain medication directly into the intrathecal space around the spinal cord ma...
Minimally Invasive Bleb Surgery for Glaucoma: A Health Technology Assessment [0.03%]
青光眼的微创滤过泡手术：一项卫生技术评估
Ontario Health
Ontario Health
Background: Glaucoma is the term for a group of eye disorders that causes progressive damage to the optic nerve, which can lead to visual impairment and, potentially, irreversible blindness. Minimally invasive bleb surger...
Bariatric Surgery for Adults With Class I Obesity and Difficult-to-Manage Type 2 Diabetes: A Health Technology Assessment [0.03%]
手术治疗成人肥胖和难治性第二型糖尿病：一项医疗技术评估
Ontario Health (Quality)
Ontario Health (Quality)
Background: Many individuals with type 2 diabetes are classified as either overweight or obese. A patient may be described as having difficult-to-manage type 2 diabetes if their HbA1c levels remain above recommended targe...
Comparative Study
Ontario health technology assessment series. 2023 Dec 5;23(8):1-151. DOI: 2023
Robotic-Assisted Partial Nephrectomy for Kidney Cancer: A Health Technology Assessment [0.03%]
机器人辅助的肾部分切除术治疗肾脏癌症：卫生技术评估报告
Ontario Health (Quality)
Ontario Health (Quality)
Background: Robotic-assisted surgery has been used in Ontario hospitals for over a decade, but there is no public funding for the robotic systems or the disposables required to perform robotic-assisted surgeries ("robotic...
Robotic-Assisted Hysterectomy for Endometrial Cancer in People With Obesity: A Health Technology Assessment [0.03%]
肥胖人群机器人辅助子宫切除术治疗子宫内膜癌：一项卫生技术评估
Ontario Health (Quality)
Ontario Health (Quality)
Background: Robotic-assisted surgery has been used in Ontario hospitals for over a decade, but there is no public funding for the robotic systems or the disposables required to perform robotic-assisted surgeries ("robotic...
First-Trimester Screening Program for the Risk of Pre-eclampsia Using a Multiple-Marker Algorithm: A Health Technology Assessment [0.03%]
早孕期使用多种标志物算法筛查子痫前期风险的项目卫生技术评估
Ontario Health (Quality)
Ontario Health (Quality)
Background: Pre-eclampsia is when high blood pressure develops after 20 weeks of pregnancy and either proteinuria, maternal end-organ dysfunction, or uteroplacental dysfunction causing fetal growth restriction also develo...
Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment [0.03%]
囊性纤维化、脆性X综合征、血红蛋白病和地中海贫血及脊髓性肌萎缩症的携带者筛查项目：卫生技术评估报告
Ontario Health (Quality)
Ontario Health (Quality)
Background: We conducted a health technology assessment to evaluate the safety, effectiveness, and cost-effectiveness of carrier screening programs for cystic fibrosis (CF), fragile X syndrome (FXS), hemoglobinopathies an...
Homologous Recombination Deficiency Testing to Inform Patient Decisions About Niraparib Maintenance Therapy for High-Grade Serous or Endometrioid Epithelial Ovarian Cancer: A Health Technology Assessment [0.03%]
用于指导患者关于尼拉帕利维持治疗以改善高级别浆液性或子宫内膜样卵巢癌预后的同源重组缺陷检测：一项卫生技术评估
Ontario Health (Quality)
Ontario Health (Quality)
Background: Ovarian cancer affects the cells of the ovaries, and epithelial cancer is the most common type of malignant ovarian cancer. The homologous recombination repair pathway enables error-free repair of DNA double-s...
Placental Growth Factor (PlGF)- Based Biomarker Testing to Help Diagnose Pre-eclampsia in People With Suspected Pre-eclampsia: A Health Technology Assessment [0.03%]
基于胎盘生长因子(PLGF)的生物标志物检测在疑似子痫前期患者中帮助诊断子痫前期的技术评估报告
Ontario Health (Quality)
Ontario Health (Quality)
Background: Pre-eclampsia is a potentially serious condition affecting up to 5% of pregnancies, most frequently after 20 weeks' gestation. Placental growth factor (PlGF)-based tests measure either the blood level of PlGF ...
Wire-Free, Nonradioactive Localization Techniques to Guide Surgical Excision of Nonpalpable Breast Tumours: A Health Technology Assessment [0.03%]
无导线、非放射性定位技术在指导非触及乳腺肿瘤手术切除中的应用：卫生技术评估报告
Ontario Health (Quality)
Ontario Health (Quality)
Background: The current standard treatment for nonpalpable breast tumours is surgical excision; however, it is nearly impossible to locate these small masses during surgery. Therefore, a marker must be implanted into the ...